News & Politics
The technology that is helping us combat COVID-19 is also poised to help us tackle tough infectious and non-infectious diseases. Immunologist Sarah Fortune explains how these vaccines work, and how the mRNA platform could transform the prevention and treatment of deadly diseases.In this episode of "Better Off," Harvard Chan School immunologist Sarah Fortune takes on common misconceptions about COVID-19 vaccines, and discusses the ways that mRNA technology could be used to create vaccines for diseases like TB and cancer.Guest: Sarah Fortune, John LaPorte Given Professor of Immunology and Infectious Diseases, Chair, Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public HealthFor a full transcript of this episode, visit our website. Subscribe to get new episodes of Better Off in your podcast feed every other Wednesday.Read more about Sarah Fortune's work, as well as the latest news from Harvard T.H. Chan School of Public Health at hsph.harvard.edu/news. Music in this episode:Ketsa – SabreBlue Dot Sessions – St. Augustine RedBlue Dot Sessions – Solear InterludeBlue Dot Sessions – Ewa Valley